Small Cell Lung Cancer Treatment - National Cancer Institute
Expert-reviewed information summary about the treatment of small cell lung cancer. Small Cell Lung Cancer Treatment (PDQ®) Last Modified: 05/22/2008 more

MedlinePlus Medical Encyclopedia: Lung cancer - small cell
Small cell lung cancer usually starts in the air tubes (bronchi) in the center of the chest..It tends to spread much more quickly than non-small cell lung cancer more

Cancer Information, Research, and Treatment for all Types of Cancer ...
Small cell lung cancer (SCLC) - the rarer of the two types Non small cell lung cancer (NSCLC) - the more common of Small Cell Lung Cancer - divided more

InteliHealth:
.Usually, small cell cancer of the lung has spread widely at the first time of Small cell lung cancers spread to any area of the body more

Lung Cancer Home Page - National Cancer Institute
Information about lung cancer treatment, prevention, causes, screening, clinical trials, research, Clinical Trials to Prevent Non-Small Cell Lung Cancer more

Small Cell Lung Cancer Prognosis, Stages, Small Cell Lung Cancer ...
OVERVIEW OF PDQ small cell lung .TO LEARN MORE.Limited stage.Extensive stage RECURRENT SMALL CELL LUNG CANCER.Stages of small cell lung cancer more

MedlinePlus Medical Encyclopedia: Lung cancer - non-small cell
There are many different types of treatment for non-small cell lung cancer: .It usually grows and spreads more slowly than small cell lung cancer more

Small cell lung cancer
Recurrent Small Cell Lung Cancer.Overview Of PDQ What is small cell lung cancer? Small cell lung cancer is usually found in people who .To Learn More more

ACS :: What Is Small Cell Lung Cancer?
Note: This document is only about the small-cell type of lung cancer. The information here only covers small cell lung cancer. more

Small Cell Carcinoma Lung Cancer | Small Cell Lung Cancer | Metastatic ...
Small cell lung cancer information center – general information on small cell RECURRENT SMALL CELL LUNG CANCER.GENERAL INFORMATION more

small cell lung cancer

TUSTIN, Calif., July 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported that its lead product candidate bavituximab achieved the pre-specified Stage 1 primary endpoint in its ongoing Phase II clinical trial in ... more

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that patient screening and dosing has begun in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with non-small cell lung ... more